wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33377668-1F197844-BF19-4973-9A79-4821F087A4D9
Q33377668-1F197844-BF19-4973-9A79-4821F087A4D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33377668-1F197844-BF19-4973-9A79-4821F087A4D9
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
P2860
Q33377668-1F197844-BF19-4973-9A79-4821F087A4D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33377668-1F197844-BF19-4973-9A79-4821F087A4D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b803dabd2861832dbb312e97c833289102799bf
P2860
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.